MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.86M
P/E Ratio
0.01
Total Cash
3.42M
Projected Growth
N/A
Total Debt
948.96K
Revenue
4.83M
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
2.83
Total Debt/Equity
N/A
Revenue/Share
6.81 USD as % of share price
Fundamentals
INM
Capitalization
3.86M
P/E Ratio
0.01
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
3.42M
Total Cash/Share
2.83
Total Debt
949K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.81%
Revenue
4.83M
ROE
N/A
Book Value
6.18M
P/B Ratio
0.55
Cash Flow
N/A
Earnings
-12.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84.5M
Current Ratio
3.05
Current Revenue Per Employee
95400.00
Dividends Per Share - Security
N/A
EBITDA
-7.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
41.46
Revenue To Assets
-66.62
Shares Held By Institutions
227K
Shares Outstanding - Current
1.21M
Total Liabilities
2.32M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-42.702
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com